The antibiotically bioactive thiopeptide compound kocurin was identified in extracts from a newly isolated Kocuria rosea strain. The axenic strain was retrieved from a soil sample of the intertidal area at the Paracas National Park, Peru. The genetic basis of this promising natural product with activity against methicillin-resistant Staphylococcus aureus (MRSA) strains was revealed by comparative genome analysis of this new isolate and other reported thiopeptide producer strains. The functionality of the predicted gene locus was experimentally proven by heterologous expression in Streptomyces coelicolor M1146. Expression of the gene cluster under the control of a constitutive promoter enabled the transgenic strain to produce kocurin in selected media. The kocurin biosynthetic gene cluster comprises nine open reading frames and spans around 12 kbp of the genome.
The increasing antibiotic resistance of pathogenic bacteria has become a serious threat towards human health [1] . Hence, new treatment options, e.g. novel antibiotics, are urgently needed [2] . To refill the antibiotic development pipeline, bioprospecting projects have been revived, especially in the academic environment, all around the globe. Natural products have always been the most rewarding resource for novel compounds with intriguing bioactivities. Even though the low-hanging fruits seem to have been harvested, since previously known compounds have been reisolated in activity-based approaches, nature still has an untapped reservoir of natural products harbouring interesting activities from a pharmaceutical point of view [3] .
In the present report, the search for new antibiotically active compounds from marine bacteria, isolated from the Peruvian coastline, led to the isolation of a strain whose ethyl acetate crude extract showed strong antibiotic activity against Gram-positive test strains, i.e. Arthrobacter cristallopoietes, Bacillus megaterium and MRSA. 16S rDNA identification revealed the isolate to be 99 % identical to Kocuria rosea DSM 20447 (accession number: NR_044871.1). Analysing the fractionated crude extract by subsequent HPLC-MS/MS resulted in the identification of the known thiopeptide compound kocurin as the molecule responsible for the antibiotic activity (Fig. S1 , Table S1 , available in the online Supplementary Material).
Kocurin is regarded as a compound with promising properties, which could potentially lead to the development of a novel antibiotic [3] . The substance was first described as compound PM181104, and a patent for the treatment of Clostridium difficile-associated infections was claimed (WO2014102570 A1). In 2013 the group of Genilloud and Reyes published an alternative structure to the one shown in the patent and named the compound kocurin. They investigated marine actinomycetes of the family Micrococcaceae, whereby the strains had been isolated from sponges. Structure elucidation was achieved using a combination of spectroscopic and chemical methods, which included extensive NMR analysis, HRMS and MS/MS fragmentation, as well as chemical degradation and Marfey's analysis of the resulting amino acid residues [4] . Thiazolyl peptide antibiotics are a class of natural products showing in vitro activity against Gram-positive bacteria. Meanwhile, about 100 molecules of this type were reported [5] . Based on the promising in vitro activity of kocurin, in vivo tests were performed. Using a BALB/c mouse septicaemia model, kocurin showed promising activity. It displayed 100 % effective dose (ED 100 ) values of 2.5 and 5.0 mg kg À1 body weight against MRSA and of 10.0 mg kg À1 against vancomycin-resistant enterococci [6] .
In this study, it was projected to identify the genetic basis of kocurin biosynthesis, i.e. to identify the corresponding biosynthetic gene cluster (BGC). Genomic sequence data from several Kocuria strains were analysed using antiSMASH [7] . In general, members of the family Micrococcaceae possess a small genome (2.7-4 Mbp) compared with other families of actinobacteria such as Streptomycetaceae [8] . The overall number of BGCs observed after analysis of the eight available genomes of Kocuria species ranged between 2 and 9. Most of the predicted BGCs were type III polyketide synthases (PKSs), bacteriocins, siderophores and thiopeptides, with only a very small number of modular PKSs and nonribosomal peptide synthetases (NRPSs).
Formerly it was speculated that the biosynthesis of kocurin is encoded by a NRPS/PKS system [3] . However, this was proven wrong following investigation of the biosynthesis of thiomuracins in Nonomuraea species [9] , and a closer look at the predicted BGCs in our strain revealed that no hybrid NRPS/PKS BGC seems to be associated with kocurin production. Instead, a predicted ribosomally biosynthesized and post-translational modified peptide (RiPP) gene cluster harboured a small gene that might encode the precursor peptide of kocurin. Hence, this BGC was attributed to kocurin production.
In silico analysis revealed two putative kocurin BGCs, in Kocuria UCD-OTCP (accession number: NZ_AOSQ01000025) and in Kocuria flava HO-9041 (accession number: NZ_CP013254), that could be related to thiopeptide biosynthesis. The biosynthesis of the thiopeptide antibiotics GE2270 (from Planobispora rosea) and GE37468 (from Streptomyces ATCC55365) was recently characterized [10, 11] . Both molecules show structural similarity, as well as a related mode of action to kocurin. Both groups reported the ribosomal origin of the investigated peptide. The RiPPs are initially synthesized from a larger propeptide, which is post-translationally modified by heterocyclization, serine dehydratation, amidation and macrocyclization to the final product. The resulting molecules normally have a mass in the range of 1100-1600 Da.
Screening the sequence data for a putative kocurin propeptide (amino acid sequence: STNCFCYPCCSCSAPSS) revealed suitable genes in both predicted BGCs. Based on this strong indication for the in silico identification of the kocurin BGC, the presence of a homologous BGC in our producer strain was attempted. The primer pair Koc_scre_f and Koc_scre_r was thus designed, which targets the propeptide gene region and a fragment of the adjacent dehydratase gene (Supplementary information). PCR using the genomic DNA of K. rosea s17 as template resulted in the amplification of a fragment with an expected size of 1.1 kbp.
Sequencing revealed 100 % identity at the nucleotide level with Kocuria sp. UCD-OTCP and 91 % with K. flava HO-9041. As a next step, K. rosea s17 was genome sequenced using Illumina sequencing and assembled using Spades. Performing antiSMASH analysis on the assembled sequence data, a contig was identified harbouring the complete gene locus linked to kocurin production. The overall identity at DNA level to sequences available in databases is 99.6 % and the organization of the cluster is identical.
To prove the predicted link between the BGC and the metabolite experimentally, heterologous expression was envisaged. Therefore, the boundaries of the cluster were first defined. A closer examination of the predicted function of the proteins encoded by the open reading frames neighbouring the propeptide sequence enabled the identification of eight genes downstream in the same orientation that have a predicted role in kocurin biosynthesis (Fig. 1) . This region spans 12.1 kbp and the genes were named kocA-I (from kocurin). Upstream of the propeptide encoding kocA, a gene coding for a HEAT repeat containing protein was identified in the opposite orientation, but its function was considered not to be involved in kocurin biosynthesis. Downstream of the ABC transporter gene kocI, a group of genes involved in general stress response was detected, forming the other border of the BGC (Fig. 1) .
Two different Streptomyces strains were chosen for heterologous expression. One strain was the well-characterized Streptomyces coelicolor M1146 that is optimized for the expression of specialized metabolites due to the deletion of host-specific BGCs [12] . The thiopeptide GE2270 was expressed successfully in this strain [10] . The second strain was Streptomyces sp. s120, a strain that was isolated in the same bioprospecting project as K. rosea s17. This strain was chosen due to its fast growth rate and genetic tractability.
To clone the kocurin BGC to express it in a heterologous host, it was amplified by PCR in three parts using the reverse and forward primer pairs koc1-3 (Table S2 ). The internal primers created a 35 bp homologous region between the DNA fragments generated by PCR and the external primers added 35 bp with homology to both flanks of the HindIII-linearized, integrative expression vector pSET152ermE* [13] . The three PCR products were joined with the linearized vector using Gibson assembly (1 h at 50 C). Subsequently, 5 µl of the reaction mixture were added to 200 µl CaCl-competent E. coli XL1blue cells. Transformation was achieved by 20 min on ice, 90 s heat shock at 42 C, followed by addition of 1 ml Luria Bertani (LB) medium and 90 min incubation at 37 C for regeneration. Subsequently, aliquots were plated onto apramycin-containing (50 µg ml
À1
) LB agar plates. After overnight incubation few colonies were observed. These were tested by colony PCR for the presence of the BGC (Supporting information).
From positive clones, the plasmid pSET152-Koc was isolated (Pureyield Promega plasmid isolation Kit, following the manufacture's protocol) and restricted with SacI. Eight out of ten plasmids showed the expected restriction pattern and were sequenced. The validated plasmid pSET152-Koc was transferred into E. coli ET12567, a methylation-deficient strain [14] . Then, triparental conjugation was performed using additionally E. coli ET12567 cells carrying the pUB307 helper plasmid and the targeted Streptomyces host strain. In brief, the E. coli strains were cultured overnight in chloramphenicol (25 µg ml À1 ) containing LB broth plus kanamycin (50 µg ml À1 ) in the case of E. coli ET12567-pUB307, and apramycin (50 µg ml À1 ) for E. coli ET12567-pSET152-Koc. A volume of 200 µl of this preculture was used to inoculate 20 ml LB broth containing the same antibiotics, and incubation was performed at 37 C. When the cultures reached an OD 600 of 0.5, cells were recovered by centrifugation (3500 g, 5 min) and washed twice with 20 ml LB medium. The resulting pellet was resuspended in 500-1000 µl LB medium. A volume of 100 µl of each was mixed together with 100 µl of a Streptomyces spore solution, which was previously activated (10 min, 50 C in 2YT medium). The mixture was directly plated on SFM agar plates supplemented with 10 mM MgCl 2 . After 16 h at 30 C, the plates were covered with 1 ml H 2 O containing 400 µg nalidixic acid and 1 mg apramycin. Conjugants were observed after 24 and 48 h for Streptomyces sp. S120 and S. coelicolor M1146, respectively. Colonies were picked and streaked onto new apramycin/nalidixic acid containing SFM agar plates. After 72 h single colonies were picked and tested by colony PCR for kocurin BGC integration. Subsequent sequencing verified the integration of the kocurin BGC for both strains.
Heterologous expression of thiopeptide gene clusters is most challenging. Hence, the projected expression of the thiopeptide TP1161 in Streptomyces coelicolor M512 remained unsuccessful [15] , and the compound GE2270 was only expressed in 1 out of 35 different media tested [10] . Using the two transgenic strains generated here, five different production media were used, i.e. SM13 and medium C used previously for GE2270 expression in Streptomyces and Planobispora [10, 16] , as well as AF, SFM and ISP2 medium [17] . A preculture was inoculated by using spores of the transgenic strains in ISP2 medium and incubated 48 h at 30 C. Then, 2 ml were used to inoculate 100 ml of the various media; fermentation was performed for 4 d at 30 C in 300 ml baffled flasks. Subsequently, the cultures were extracted using 2Â300 ml of ethyl acetate for liquid-liquid separation. The organic layer was collected, combined and dried by evaporation. The resulting extract was dissolved in methanol (2 mg ml À1 ). Samples were analysed by HPLC/MS-MS [gradient: 10 to 100 % acetonitrile over 20 min, EC10/2 Nucleoshell C18 2.7 µm column (Macherey-Nagel)]. [10, 11] . Genes are drawn to scale; size bar is on the top line. (b) Amino acid alignment of selected thiopeptide propeptides. Three kocurin producers (K. rosea s17, K. flava HO9041 and K. UCD-OTCP), as well as the producers of GE37468 (S. ATCC 55365) and GE2270 (P. rosea), are shown. Black lines indicate the three parts of the propeptide chain; both the leader peptide and the C-terminal residues are cleaved off to form the mature peptide.
An extract of the native producer K. rosea s17 served as positive control, and S. coelicolor M1146 carrying the empty pSET152 vector and the respective cell-free production medium as negative control. A peak matching the expected kocurin retention time (12.2-12.4 min) was only detected in S. coelicolor M1146-Koc grown in ISP2 medium. ). In AF medium, only traces were observed, while no kocurin production was observed for Streptomyces sp s120 in any of the culture media used (Fig. 2) .
The observed production level is very low under the conditions used. This is in accordance with previous heterologous expression attempts for thiopeptides in Streptomyces, whereby the media used seem to have a strong influence on expression [10] . In future, further optimization will be necessary to improve the kocurin titre. It might be speculated that the toxicity of the compound can affect the growth and metabolism of the heterologous host at early stages of the life cycle, since visible biomass production started 3 days post-inoculation. Hence, using inducible promoters could be a feasible option to overcome this. Another strategy would be the overexpression of the resistance gene. It was shown before that this resulted in improved GE2270 production yields [10] . However, a reported self-resistance gene for an alternative copy of the elongation factor EF-Tu was not found in the entire genome. Therefore, it can be assumed that the ABC transporter KocI fulfils the immunity function, as suggested for GE37468 [11] . Furthermore, the EF-Tu of the original producer can be resistant towards the thiopeptide as is the case for the GE2270 producer Planobispora rosea [10] . This might explain why growth of the heterologous host used in this study was retarded, since no additional resistant version of an EF-Tu gene was cloned with the BGC. Another option is to use Nonomuraea species as the heterologous host, since GE2270 production levels could be increased up to 250 mg l À1 [18] .
A putative kocurin biosynthesis is proposed based on comparative analysis with the BGCs of GE2270 and GE37468 and considering the recent work performed by the van der Donk and Mitchell groups [19] (Fig. 3 and Table S3 ). The propeptide-coding gene kocA is located at the upstream end of the BGC and codes for 58 amino acids, divided into a leader peptide (39 amino acids), a core peptide (17 amino acids) and a C-terminal Ser-Ala residue that is cleaved off during maturation. Also in GE2270 and GE37468, either terminal Ser-Ala or Asp is excised during maturation (Fig. 1) . The genes coding for the post-translational modifying enzymes are situated downstream of kocA. First, the oxazole and thiazol(ine) rings are formed, catalysed by KocE-G (Fig. 3) . These proteins resemble McbC-type dehydrogenases (KocE, G) and a YcaOlike cyclodehydratase (KocF) [20] .
The serine residues present in the core peptide should be dehydrated through the action of KocB and KocC, both lantibiotic-type dehydratases. However, the exact timing of the reactions is still unknown. The C-terminus is shortened by the excision of the last two amino acid residues and amidated by the action of KocH. For the thiopeptides berninamycin and microccocin C, it was shown that this step is essential for the final cyclization reaction [21, 22] . Finally, the last step is the +1 to +11 cyclization, yielding a 29-membered macrocycle, by forming the central pyridine ring through an aza-Diels-Alder reaction catalysed by KocD. In koc-BGC, kocI is additionally found at the downstream end encoding for an ABC transporter.
In conclusion, the results presented here provide the experimental proof for kocurin BGC and enable future studies on this antibiotic molecule. On the one hand, a heterologous expression system using well-investigated actinobacterial strains is the method of choice for up-scaling experiments.
Hence, in addition to biosynthetic derivatization it might become feasible to produce sufficient quantities in a sustainable approach to perform chemical modifications on the mother molecule. On the other hand, the generation of derivatives, e.g. molecules with exchanged amino acids, is facilitated by this system. 
